Fruitful decade for antileishmanial compounds from 2002 to late 2011
Leishmaniasis, usually caused by the genus Leishmania, has not received the attention it
deserves and in recent times has developed into a major health problem worldwide. 1, 2 …
deserves and in recent times has developed into a major health problem worldwide. 1, 2 …
Insights into the current status of privileged N-heterocycles as antileishmanial agents
Leishmania, one of the most important neglected tropical diseases, is endemic in several
regions of the world and hence regarded as a serious threat to public health. Major …
regions of the world and hence regarded as a serious threat to public health. Major …
Quinolinyl and quinolinyl N-oxide chalcones: synthesis, antifungal and cytotoxic activities
L de Carvalho Tavares, S Johann… - European Journal of …, 2011 - Elsevier
A series of new 6-quinolinyl and quinolinyl N-oxide chalcones were efficiently prepared. All
chalcones were tested by minimal inhibitory concentration (MIC) against three species of …
chalcones were tested by minimal inhibitory concentration (MIC) against three species of …
Green synthesis of chalcones and microbiological evaluation
M Ritter, RM Martins, SA Rosa, JL Malavolta… - Journal of the Brazilian …, 2015 - SciELO Brasil
A green method was developed for the synthesis of chalcones using glycerin as solvent.
Subsequently, the potential microbiology activity of these molecules was evaluated by …
Subsequently, the potential microbiology activity of these molecules was evaluated by …
Prediction of antileishmanial compounds: general model, preparation, and evaluation of 2-acylpyrrole derivatives
C Santiago, B Ortega-Tenezaca, I Barbolla… - Journal of Chemical …, 2022 - ACS Publications
In this work, the SOFT. PTML tool has been used to pre-process a ChEMBL dataset of pre-
clinical assays of antileishmanial compound candidates. A comparative study of different ML …
clinical assays of antileishmanial compound candidates. A comparative study of different ML …
Discovery and molecular docking of quinolyl-thienyl chalcones as anti-angiogenic agents targeting VEGFR-2 tyrosine kinase
SUF Rizvi, HL Siddiqui, M Nisar, N Khan… - Bioorganic & medicinal …, 2012 - Elsevier
Vascular endothelial growth factor Receptor-2 (VEGFR-2) kinase inhibition is one of the well
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …
established strategies to promptly tackle tumor growth by suppression of angiogenesis. In …
In Vitro Activities of New 2-Substituted Quinolines against Leishmania donovani
ABSTRACT A series of 9 quinolines and 18 styrylquinolines was evaluated for the drugs' in
vitro antileishmanial activities and cytotoxicities. The 7-aroylstyrylquinoline scaffold …
vitro antileishmanial activities and cytotoxicities. The 7-aroylstyrylquinoline scaffold …
Quinoline containing chalcone derivatives as cholinesterase inhibitors and their in silico modeling studies
Cholinesterases (ChEs) play a vital role in regulating cholinergic transmission. Inhibition of
ChEs is thought to be an emerging and useful therapeutic target for neurodegenerative …
ChEs is thought to be an emerging and useful therapeutic target for neurodegenerative …
Novel halogenated pyrazine-based chalcones as potential antimicrobial drugs
M Kucerova-Chlupacova, V Vyskovska-Tyllova… - Molecules, 2016 - mdpi.com
Chalcones, ie, compounds with the chemical pattern of 1, 3-diphenylprop-2-en-1-ones, exert
a wide range of bio-activities, eg, antioxidant, anti-inflammatory, anticancer, anti-infective …
a wide range of bio-activities, eg, antioxidant, anti-inflammatory, anticancer, anti-infective …
Recent advances on the synthesis of chalcones with antimicrobial activities: A brief review
M Ritter, R Mastelari Martins, D Dias… - Letters in Organic …, 2014 - ingentaconnect.com
The increasing resistance of bacteria and fungi to antimicrobial drugs has been a matter of
concern in public health in the last decades. The continuing need for novel therapeutic …
concern in public health in the last decades. The continuing need for novel therapeutic …